Skip to main content

Steve’s story: An interventional approach to pancreatic cancer

Being diagnosed with advanced metastatic pancreatic cancer was a grim experience for Steve Price.

But thanks to his doctors at Weill Cornell Medicine and NewYork-Presbyterian, state-of-the-art interventional radiology allowed him to receive chemotherapy immediately after biopsy, shrinking his tumors dramatically. Then, a precision medicine clinical trial revealed that Price had a mutation in the BRCA1 gene, normally associated with breast cancer.

By examining his unique genetic profile, Price’s medical team was able to determine that a new therapy targeting the mutation could give him his life back.

- Weill Cornell Medicine

Media Contact

Jennifer Gundersen